跳至主要内容
临床试验/KCT0005536
KCT0005536已完成未知

A retrospective, multi-center, single-blind, pivotal trial to assess clinical equivalence with stage II and III advanced gastric cancer based on the 6th and 8th of the AJCC.

ational Cancer Center0 个研究点目标入组 2,131 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
2,131

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational Study

入排标准

年龄范围
19(Year) 至 o Limit(—)
性别
All

入选标准

  • 1) Sample providers criteria
  • ? Male and female adult patients aged 19 years or over
  • ? Postoperative patients with gastric cancer invading the submucosal layer and having 3 or more lymph nodes metastasis or who with gastric cancer infiltration of muscularis propria with lymph node metastasis (stage II and III advanced gastric cancer patients, 8th of the AJCC)
  • ? Patients who have not received neoadjuvant chemotherapy and radiotherapy
  • ? Patients with pathological record and clinical information after surgery from archived FFPE samples between 2005 and 2010
  • ? Patients who have not been included in discovery clinical trial (No. 705) and confirmatory clinical trial (No. 745)
  • ?Patients who have undergone a radical gastrectomy and who show no evidence of residual tumors as observed with the unaided eye or through a microscope
  • 2) Sample criteria
  • ? The FFPE tumor specimens in storage have a tumor amount of at least 20% and therefore can be tested.
  • ? The quantity (not less than 400ng) and quality (A260/280 of not less than 1.8) of RNA are sufficient for analysis.

排除标准

  • 1)Exclusion Criteria
  • ? Male and female patients aged less than 19 years
  • ? Postoperative patients with gastric cancer invading the mucosa and submucosal layer and having less than 3 lymph nodes metastasis or who with gastric cancer infiltration of muscularis propria without lymph node metastasis (stage II and III advanced gastric cancer patients, 8th of the AJCC)
  • ? Patients who have received neoadjuvant chemotherapy or radiotherapy
  • ? Patients without pathological record and clinical information after surgery from archived FFPE samples between 2005 and 2010
  • ? Patients who have been included in discovery clinical trial (No. 705) and confirmatory clinical trial (No. 745)
  • ? Patients with residual tumors after surgery
  • 2) Sample criteria
  • ? The FFPE tumor specimens in storage have a tumor amount of less than 20% and therefore cannot be tested
  • ? The quantity and quality of RNA are not sufficient for analysis

研究者

发起方
ational Cancer Center

相似试验